{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9Y4L1",
      "entity_text" : "ORP150",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0597" ],
      "CellLine" : [ "cellosaurus:CVCL_0062" ],
      "Cellular_component" : [ "go:GO:0070062" ],
      "Organ" : [ "uberon:UBERON:0005910" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0002327" ]
    }
  },
  "verbose_text" : "Using a lectin microarray and LC-MS/MS, Tian et al. showed that the sialoglycoproteins LAMP1 and ORP150 were overexpressed in the SW1990 human pancreatic cancer line.102 Using the same strategy, Zhu et al. identified differentially expressed glycoproteins in pancreatic cancer CD24+ CD44+ stem like cells and observed significantly increased fucosylated and galactosylated glycoproteins, such as cytokeratin 8/CK8, integrin beta1 / CD29, ICAM1 / CD54, and ribophorin 2/RPN2, in CD24+ CD44+ cells.103 Resistance to current pancreatic cancer therapies is heavily attributed to cancer stem cells (CSC).",
  "reading_complete" : "2020-08-04T14:09:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:03:40Z",
  "trigger" : "overexpressed",
  "evidence" : [ "ORP150 were overexpressed" ],
  "pmc_id" : "7050261",
  "score" : 0
}